Bristol-Myers Squibb

Exelixis, Inc. and Bristol-Myers Squibb Co. Gear Up for Round 2 of the Kidney Cancer Drug Battle Royale
Motley Fool
Thu, 09/14/17 - 06:56 pm
Exelixis
Bristol-Myers Squibb
kidney cancer
Cabometyx
Opdivo
Yervoy
Bristol To Pay Halozyme $105 Million To Make New Cancer Drugs Easier To Take
Forbes
Thu, 09/14/17 - 09:58 am
Bristol-Myers Squibb
Halozyme
Opdivo
Cancer patients know immuno-oncology and top drugs, but lack details: study
Fierce Pharma
Wed, 09/13/17 - 11:07 am
patients
cancer
immuno-oncology
Opdivo
Keytruda
Merck
Bristol-Myers Squibb
With Yervoy-beating data, Opdivo poised to fight melanoma's return after surgery
Fierce Pharma
Mon, 09/11/17 - 09:52 am
Yervoy
Opdivo
Bristol-Myers Squibb
melanoma
Opdivo combo shows early survival benefit in kidney cancer
BioPharma Dive
Fri, 09/8/17 - 09:34 am
Opdivo
Yervoy
Bristol-Myers Squibb
kidney cancer
FDA orders Bristol-Myers’ Opdivo to the sidelines on 3 studies as regulators explore dangers of checkpoint combos
Endpoints
Wed, 09/6/17 - 08:57 pm
FDA
Bristol-Myers Squibb
Opdivo
clinical trials
Multiple Myeloma
Infographic | The leaders of the global hepatitis-C market
Medical Marketing and Media
Thu, 08/31/17 - 09:27 am
hepatitis C
Gilead Sciences
Merck
AbbVie
Bristol-Myers Squibb
Bristol-Myers, Pfizer continue to build case for Eliquis
BioPharma Dive
Tue, 08/29/17 - 09:49 am
Bristol-Myers Squibb
Pfizer
Eliquis
blood thinners
Pharma Stocks That Could Move On New Data
Barron's
Sat, 08/26/17 - 07:36 pm
pharma stocks
AbbVie
Bayer
Novartis
Bristol-Myers Squibb
Eli Lilly
European Society of Cardiology
An analysis of 2017 first half for pharmaceutical industry
GoInPharma
Sat, 08/19/17 - 10:51 am
pharma industry
Pfizer
Sanofi
GSK
Roche
Celgene
Bristol-Myers Squibb
Opdivo Could Drive Bristol-Myers Squibb’s Revenue Growth in 2017
Market Realist
Fri, 08/18/17 - 12:14 pm
Opdivo
Bristol-Myers Squibb
Latest Immunotherapy Setback: Bristol Drugs Stumble in Kidney Cancer
Xconomy
Wed, 08/16/17 - 10:13 am
Bristol-Myers Squibb
kidney cancer
Opdivo
Yervoy
A Supreme Court pharma case deals consumers a big loss
Stat
Mon, 08/14/17 - 10:38 am
Supreme Court
consumers
Plavix
Bristol-Myers Squibb
Pharma's giants, new and old, tell more tales than their numbers show
Fierce Pharma
Fri, 08/11/17 - 11:16 am
Big Pharma
JNJ
Pfizer
GSK
Roche
Novartis
Sanofi
Bristol-Myers Squibb
The 2017 report card so far: Big Biotech largely trading up as pharma posts mixed results
Fierce Pharma
Thu, 08/10/17 - 06:58 pm
pharma stocks
Merck
Pfizer
AbbVie
Eli Lilly
Bristol-Myers Squibb
GSK
Roche
Sanofi
Bayer
Novo Nordisk
Celgene
Biogen
AstraZeneca
Bristol-Myers Squibb nixes 58 marketing jobs as HIV medications near patent cliff
Fierce Pharma
Wed, 08/9/17 - 11:20 am
Bristol-Myers Squibb
HIV
layoffs
patent cliff
Reyataz
Sustiva
Bristol-Myers beefs up big cancer drug pipeline, buying IFM drugs in $2.3B-plus deal
Endpoints
Thu, 08/3/17 - 06:22 pm
Bristol-Myers Squibb
IFM Therapeutics
oncology
M&A
Forget BMY's Q2 Earnings, Watch Out For Opdivo Trials Going Forward
Forbes
Wed, 08/2/17 - 09:21 pm
Bristol-Myers Squibb
Opdivo
clinical trials
Merck's Keytruda Plays Catch-Up to Bristol-Myers' Opdivo
Motley Fool
Wed, 08/2/17 - 09:18 am
Merck
Keytruda
Bristol-Myers Squibb
Opdivo
Bristol-Myers Squibb's Opdivo nabs MSI-H colorectal cancer nod, but it can't match Keytruda's umbrella approval
Fierce Pharma
Tue, 08/1/17 - 11:10 am
Bristol-Myers Squibb
Opdivo
colorectal cancer
Merck
Keytruda

Pages